Science & Technology · Part VI — Health, Agriculture, Defence and Society · Major topic 28 of 39
Immunology, Vaccines, Infectious Disease and Pandemic Preparedness
Immune mechanisms, vaccine design, surveillance and public-health responses to outbreaks.
107 items insideAsked 2× in the RPSC/RSSB papers we analysed, most recently 2025SNT-28
Also look at: Biology: Immunology, Host Defence & VaccinologyBiology: Immunity, Infection, Epidemiology & Public Health BiologyEconomy: Disaster Risk, Economic Resilience and Supply Chains
- 1
Historical evolution — key dates
- Smallpox vaccination is demonstrated in Jenner’s work.1796
- Pasteur’s work advances vaccine development and germ theory.1880s
- Salk polio vaccine is declared safe and effective after a large trial.1955
- WHO declares smallpox eradicated.1980
- SARS-CoV-2 emerges and COVID-19 becomes a pandemic.2019-2020
- Multiple COVID-19 vaccine platforms receive authorizations in different jurisdictions.2020-2021
- WHO ends COVID-19’s PHEIC status while noting COVID-19 remains a health issue.2023
- 2
Immune system
- Innate
- Adaptive
- Humoral
- Cellular
- Barriers
- Inflammation
- 3
Antigens
- Antibodies
- B cells
- T cells
- Memory
- Neutralization
- Antigen presentation
- 4
Vaccines
- Live attenuated
- Inactivated
- Subunit
- Conjugate
- Toxoid
- Viral vector
- MRNA
- Protein
- 5
Development
- Preclinical
- Clinical phases
- Immunogenicity
- Efficacy
- Effectiveness
- Safety surveillance
- 6
Adjuvants
- Cold chain
- Storage
- Temperature monitoring
- EVIN
- Logistics
- 7
Immunization
- Routine
- Catch-up
- Campaigns
- Equitable access
- 8
Surveillance
- Case definition
- Reporting
- Contact tracing
- Genomic surveillance
- Wastewater
- 9
Outbreak
- Epidemic
- Pandemic
- Endemic
- PHEIC
- Risk communication
- One Health
- 10
Testing
- Antigen
- Antibody
- RT-PCR
- Rapid molecular
- Sensitivity
- Specificity
- 11
Variants
- Mutation
- Selection
- Recombination
- Immune escape
- Uncertainty
- 12
COVID-19 historical source topics
- WHO naming
- Emergency authorization
- Vaccines
- Monoclonal antibodies
- Plasma therapy
- 13
Antimicrobial resistance
- Superbugs
- MDR-TB
- XDR-TB
- Stewardship
- Infection prevention
- 14
Public health law
- Epidemic Diseases Act
- Emergency procurement
- Privacy
- Civil liberties
- 15
Preparedness
- Hospital capacity
- Oxygen
- PPE
- Triage
- Dashboards
- Supply chains
- 16
Vaccine confidence
- Misinformation
- Community engagement
- Adverse-event monitoring
- Communication
- 17
Teaching sequence and cross-links
- The source’s COVID chapter is preserved as a historical snapshot
- Current guidance should come from WHO and India’s health authorities.
